Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
Study Details
Study Description
Brief Summary
The purpose of this study is to find out what effects (good and/or bad) treatment with chemotherapy and stem cell transplant compared with chemotherapy alone will have on primary CNS B-cell lymphoma. Currently the best treatment for patients with primary CNS B-cell lymphoma is not known.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Detailed Description
Primary Objective:
To compare the two-year progression-free survival (PFS) of patients treated with the myeloablative consolidation treatment strategy of HDT/ASCT versus those treated with non-myeloablative consolidation chemotherapy with cytarabine and etoposide
Secondary Objectives:
-
To compare the two-year event-free survival (EFS) of patients treated with consolidation HDT/ASCT versus those treated with consolidation chemotherapy consisting of etoposide and cytarabine
-
To compare the overall survival (OS) of patients treated with the consolidation HDT/ASCT versus those treated with consolidation chemotherapy consisting of etoposide and cytarabine
-
To assess the toxicities associated with consolidation HDT/ASCT versus consolidation consisting of etoposide and cytarabine
-
To determine diffusion MRI metrics (ADCmini, ADC25%, and ADCmean) prior to induction chemotherapy, after one full induction chemotherapy cycle, and at the end of induction chemotherapy as a predictor of response and outcome (CALGB 581101)
-
To determine brain FDG-PET metrics (tumor SUV and tumor versus background SUV) prior to induction chemotherapy, after one full induction chemotherapy cycle, and at the end of induction chemotherapy as a predictor of response and outcome (CALGB 581101)
-
To determine whether low baseline ADC measurements are associated with shorter PFS and OS (CALGB 581101)
-
To determine whether reduction in tumor SUV by > 25% on brain FDG-PET/CT after one cycle of induction therapy is associated with improved PFS and OS (CALGB 581101)
-
To determine which IHC-based biomarkers are predictive of an adverse prognosis (CALGB
- To determine which IHC-based biomarkers are predictive of a favorable prognosis (CALGB
- for BCL6 (B-cell CLL/lymphoma 6), and STAT 6 (signal transducer and activator of transcription 6, interleukin-4 induced)
-
To analyze tumor tissue for gene expression profiles, and to correlate these profiles with treatment outcomes (CALGB 151113)
-
To determine whether CSF proteome is a predictor of outcomes (prognostic marker) irrespective of treatment arm (CALGB 151113) for (IL-10 (interleukin 10) and C3 (complement component 3)
-
To assess the neurocognitive function of patients treated with consolidation HDT/ASCT versus those treated with consolidation chemotherapy (etoposide and cytarabine) as measured by serial administration of the International PCNSL Collaborative Group (IPCG) neurocognitive battery and evaluate the long-term survivorship differences between the two arms (CALGB 71105)
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Arm I Patients undergo induction therapy for five cycles as defined in the protocol. Patients undergo stem cell transplant. |
Drug: carmustine
Given IV
Drug: thiotepa
Given IV
Procedure: stem cell transplant
Drug: G-CSF
|
Other: Arm II Patients undergo induction therapy for five cycles as defined in the protocol. Patients undergo consolidation chemotherapy. |
Drug: cytarabine
Given IV
Drug: etoposide
Given IV
Drug: G-CSF
|
Outcome Measures
Primary Outcome Measures
- progression free survival [Up to 10 years]
Secondary Outcome Measures
- event free survival [Up to 10 years]
- number of participants with treatment-related adverse events as assessed by CTCAE v4.0 [Up to 10 years]
- overall survival [Up to 10 years]
Eligibility Criteria
Criteria
-
Documentation of Disease: Diagnosis of primary CNS diffuse large B-cell lymphoma confirmed by one of the following: brain biopsy or resection, cerebrospinal fluid and vitreous fluid.
-
Other Lymphomas: Patients must have no evidence or history of non-Hodgkin lymphoma (NHL) outside of CNS.
-
Previous Treatment: Patients must have no prior chemotherapy or radiation therapy for lymphoma.
-
Age- Patients must be between the ages of 18 and 75 years.
-
Karnofsky Performance Scale - Patients must measure Karnofsky Performance Scale ≥ 30 (≥ 50 for patients ages 60-70).
-
Pregnancy and Nursing Status - Patients must be non-pregnant and non-nursing; women of childbearing potential must have a negative serum or urine pregnancy test 10-14 days prior to registration; in addition, women and men of childbearing potential must commit to use an effective form of contraception throughout their participation in this study; appropriate methods of birth control include abstinence, oral contraceptives, implantable hormonal contraceptives, or double barrier method (diaphragm plus condom)
-
HIV - Patients must have negative HIV serology.
-
Hepatitis - Patients must have negative HCV serology (unless HBsAb positive patient has recently received HBV vaccine, in this case HBcAb should be negative). All patients must be screened for hepatitis B infection before starting treatment. Those patients who test positive for hepatitis B should be closely monitored for evidence of active HBV infection and hepatitis during and for several months after rituximab treatment. PCNSL patients with a history of hepatitis B infection should be treated with entecavir or lamivudine (physician discretion for choice of drug) as antiviral prophylaxis to prevent hepatitis B reactivation.
-
Organ Transplant or Immunosuppressant Therapy - Patient must have no history of organ transplantation or ongoing immunosuppressant therapy.
-
Required Initial Laboratory Values: ANC ≥ 1500/mcL, AST and ALT < 2 x upper limit of normal (ULN), total bilirubin ≤ 3 mg/dL, creatinine clearance ≥ 50 mL/min, platelet count ≥ 100,000/mcL
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Anchorage Associates in Radiation Medicine | Anchorage | Alaska | United States | 98508 |
2 | Anchorage Radiation Therapy Center | Anchorage | Alaska | United States | 99504 |
3 | Alaska Breast Care and Surgery LLC | Anchorage | Alaska | United States | 99508 |
4 | Alaska Oncology and Hematology LLC | Anchorage | Alaska | United States | 99508 |
5 | Alaska Women's Cancer Care | Anchorage | Alaska | United States | 99508 |
6 | Anchorage Oncology Centre | Anchorage | Alaska | United States | 99508 |
7 | Katmai Oncology Group | Anchorage | Alaska | United States | 99508 |
8 | Providence Alaska Medical Center | Anchorage | Alaska | United States | 99508 |
9 | Providence Saint Joseph Medical Center/Disney Family Cancer Center | Burbank | California | United States | 91505 |
10 | UC San Diego Moores Cancer Center | La Jolla | California | United States | 92093 |
11 | University of California Davis Comprehensive Cancer Center | Sacramento | California | United States | 95817 |
12 | UCSF Medical Center-Mount Zion | San Francisco | California | United States | 94115 |
13 | UCSF Medical Center-Parnassus | San Francisco | California | United States | 94143 |
14 | Yale University | New Haven | Connecticut | United States | 06520 |
15 | Moffitt Cancer Center | Tampa | Florida | United States | 33612 |
16 | Emory University/Winship Cancer Institute | Atlanta | Georgia | United States | 30322 |
17 | Saint Luke's Mountain States Tumor Institute | Boise | Idaho | United States | 83712 |
18 | Saint Luke's Mountain States Tumor Institute - Fruitland | Fruitland | Idaho | United States | 83619 |
19 | Saint Luke's Mountain States Tumor Institute - Meridian | Meridian | Idaho | United States | 83642 |
20 | Saint Luke's Mountain States Tumor Institute - Nampa | Nampa | Idaho | United States | 83686 |
21 | Saint Luke's Mountain States Tumor Institute-Twin Falls | Twin Falls | Idaho | United States | 83301 |
22 | University of Illinois | Chicago | Illinois | United States | 60612 |
23 | University of Chicago Comprehensive Cancer Center | Chicago | Illinois | United States | 60637 |
24 | Reid Health | Richmond | Indiana | United States | 47374 |
25 | University of Kansas Cancer Center | Kansas City | Kansas | United States | 66160 |
26 | Oncology Hematology Care Inc-Crestview | Crestview Hills | Kentucky | United States | 41017 |
27 | Tulane University Health Sciences Center | New Orleans | Louisiana | United States | 70112 |
28 | Johns Hopkins University/Sidney Kimmel Cancer Center | Baltimore | Maryland | United States | 21287 |
29 | Massachusetts General Hospital Cancer Center | Boston | Massachusetts | United States | 02114 |
30 | Brigham and Women's Hospital | Boston | Massachusetts | United States | 02115 |
31 | Dana-Farber Cancer Institute | Boston | Massachusetts | United States | 02215 |
32 | Bronson Battle Creek | Battle Creek | Michigan | United States | 49017 |
33 | Mercy Health Saint Mary's | Grand Rapids | Michigan | United States | 49503 |
34 | Spectrum Health at Butterworth Campus | Grand Rapids | Michigan | United States | 49503 |
35 | Borgess Medical Center | Kalamazoo | Michigan | United States | 49001 |
36 | Bronson Methodist Hospital | Kalamazoo | Michigan | United States | 49007 |
37 | West Michigan Cancer Center | Kalamazoo | Michigan | United States | 49007 |
38 | Mercy Health Mercy Campus | Muskegon | Michigan | United States | 49444 |
39 | Lakeland Community Hospital | Niles | Michigan | United States | 49120 |
40 | Spectrum Health Reed City Hospital | Reed City | Michigan | United States | 49677 |
41 | Lakeland Hospital | Saint Joseph | Michigan | United States | 49085 |
42 | Marie Yeager Cancer Center | Saint Joseph | Michigan | United States | 49085 |
43 | Munson Medical Center | Traverse City | Michigan | United States | 49684 |
44 | Metro Health Hospital | Wyoming | Michigan | United States | 49519 |
45 | Mayo Clinic | Rochester | Minnesota | United States | 55905 |
46 | Washington University School of Medicine | Saint Louis | Missouri | United States | 63110 |
47 | University of Nebraska Medical Center | Omaha | Nebraska | United States | 68198 |
48 | Weill Medical College of Cornell University | New York | New York | United States | 10065 |
49 | University of Rochester | Rochester | New York | United States | 14642 |
50 | Stony Brook University Medical Center | Stony Brook | New York | United States | 11794 |
51 | State University of New York Upstate Medical University | Syracuse | New York | United States | 13210 |
52 | Duke University Medical Center | Durham | North Carolina | United States | 27710 |
53 | Dayton Physicians LLC-Miami Valley South | Centerville | Ohio | United States | 45459 |
54 | Oncology Hematology Care Inc-Eden Park | Cincinnati | Ohio | United States | 45202 |
55 | Oncology Hematology Care Inc-Mercy West | Cincinnati | Ohio | United States | 45211 |
56 | Oncology Hematology Care Inc - Anderson | Cincinnati | Ohio | United States | 45230 |
57 | Oncology Hematology Care Inc-Kenwood | Cincinnati | Ohio | United States | 45236 |
58 | Oncology Hematology Care Inc-Blue Ash | Cincinnati | Ohio | United States | 45242 |
59 | Good Samaritan Hospital - Dayton | Dayton | Ohio | United States | 45406 |
60 | Miami Valley Hospital | Dayton | Ohio | United States | 45409 |
61 | Dayton Physicians LLC-Samaritan North | Dayton | Ohio | United States | 45415 |
62 | Samaritan North Health Center | Dayton | Ohio | United States | 45415 |
63 | Dayton NCI Community Oncology Research Program | Dayton | Ohio | United States | 45420 |
64 | Oncology Hematology Care Inc-Healthplex | Fairfield | Ohio | United States | 45014 |
65 | Armes Family Cancer Center | Findlay | Ohio | United States | 45840 |
66 | Blanchard Valley Hospital | Findlay | Ohio | United States | 45840 |
67 | Orion Cancer Care | Findlay | Ohio | United States | 45840 |
68 | Atrium Medical Center-Middletown Regional Hospital | Franklin | Ohio | United States | 45005-1066 |
69 | Dayton Physicians LLC-Atrium | Franklin | Ohio | United States | 45005 |
70 | Dayton Physicians LLC-Wayne | Greenville | Ohio | United States | 45331 |
71 | Wayne Hospital | Greenville | Ohio | United States | 45331 |
72 | Greater Dayton Cancer Center | Kettering | Ohio | United States | 45409 |
73 | Kettering Medical Center | Kettering | Ohio | United States | 45429 |
74 | Dayton Physicians LLC-Signal Point | Middletown | Ohio | United States | 45042 |
75 | Dayton Physicians LLC-Wilson | Sidney | Ohio | United States | 45365 |
76 | Springfield Regional Cancer Center | Springfield | Ohio | United States | 45504 |
77 | Springfield Regional Medical Center | Springfield | Ohio | United States | 45505 |
78 | Dayton Physicians LLC-Upper Valley | Troy | Ohio | United States | 45373 |
79 | Upper Valley Medical Center | Troy | Ohio | United States | 45373 |
80 | Surgical Associates Inc | Tulsa | Oklahoma | United States | 74136 |
81 | Warren Clinic Oncology-Tulsa | Tulsa | Oklahoma | United States | 74146 |
82 | Saint Charles Health System | Bend | Oregon | United States | 97701 |
83 | Clackamas Radiation Oncology Center | Clackamas | Oregon | United States | 97015 |
84 | Providence Oncology and Hematology Care Southeast | Clackamas | Oregon | United States | 97015 |
85 | Bay Area Hospital | Coos Bay | Oregon | United States | 97420 |
86 | Providence Milwaukie Hospital | Milwaukie | Oregon | United States | 97222 |
87 | Providence Newberg Medical Center | Newberg | Oregon | United States | 97132 |
88 | Providence Willamette Falls Medical Center | Oregon City | Oregon | United States | 97045 |
89 | Providence Portland Medical Center | Portland | Oregon | United States | 97213 |
90 | Providence Saint Vincent Medical Center | Portland | Oregon | United States | 97225 |
91 | Geisinger Medical Center | Danville | Pennsylvania | United States | 17822 |
92 | Lewistown Hospital | Lewistown | Pennsylvania | United States | 17044 |
93 | University of Pittsburgh Cancer Institute (UPCI) | Pittsburgh | Pennsylvania | United States | 15232 |
94 | Huntsman Cancer Institute/University of Utah | Salt Lake City | Utah | United States | 84112 |
95 | Central Vermont Medical Center/National Life Cancer Treatment | Berlin | Vermont | United States | 05602 |
96 | University of Vermont Medical Center | Burlington | Vermont | United States | 05401 |
97 | University of Vermont College of Medicine | Burlington | Vermont | United States | 05405 |
98 | Virginia Commonwealth University/Massey Cancer Center | Richmond | Virginia | United States | 23298 |
99 | Providence Regional Cancer System-Aberdeen | Aberdeen | Washington | United States | 98520 |
100 | Cancer Care Center at Island Hospital | Anacortes | Washington | United States | 98221 |
101 | Swedish Cancer Institute-Eastside Oncology Hematology | Bellevue | Washington | United States | 98005 |
102 | PeaceHealth Saint Joseph Medical Center | Bellingham | Washington | United States | 98225 |
103 | Providence Regional Cancer System-Centralia | Centralia | Washington | United States | 98531 |
104 | Swedish Medical Center-Edmonds | Edmonds | Washington | United States | 98026 |
105 | Providence Regional Cancer Partnership | Everett | Washington | United States | 98201 |
106 | Swedish Cancer Institute-Issaquah | Issaquah | Washington | United States | 98029 |
107 | Providence Regional Cancer System-Lacey | Lacey | Washington | United States | 98503 |
108 | PeaceHealth Saint John Medical Center | Longview | Washington | United States | 98632 |
109 | Minor and James Medical PLLC | Seattle | Washington | United States | 98104 |
110 | Pacific Gynecology Specialists | Seattle | Washington | United States | 98104 |
111 | Swedish Medical Center-Ballard Campus | Seattle | Washington | United States | 98107 |
112 | Fred Hutchinson Cancer Research Center | Seattle | Washington | United States | 98109 |
113 | Seattle Cancer Care Alliance | Seattle | Washington | United States | 98109 |
114 | Group Health Cooperative-Seattle | Seattle | Washington | United States | 98112 |
115 | Swedish Medical Center-First Hill | Seattle | Washington | United States | 98122-4307 |
116 | University of Washington Medical Center | Seattle | Washington | United States | 98195 |
117 | Providence Regional Cancer System-Shelton | Shelton | Washington | United States | 98584 |
118 | Rockwood Clinic Cancer Treatment Center-Valley | Spokane Valley | Washington | United States | 99216 |
119 | Rockwood Cancer Treatment Center-DHEC-Downtown | Spokane | Washington | United States | 99204 |
120 | PeaceHealth Southwest Medical Center | Vancouver | Washington | United States | 98664 |
121 | Compass Oncology Vancouver | Vancouver | Washington | United States | 98684 |
122 | Providence Saint Mary Regional Cancer Center | Walla Walla | Washington | United States | 99362 |
123 | North Star Lodge Cancer Center at Yakima Valley Memorial Hospital | Yakima | Washington | United States | 98902 |
124 | Providence Regional Cancer System-Yelm | Yelm | Washington | United States | 98597 |
125 | Mayo Clinic Health System-Franciscan Healthcare | La Crosse | Wisconsin | United States | 54601 |
126 | University of Wisconsin Hospital and Clinics | Madison | Wisconsin | United States | 53792 |
Sponsors and Collaborators
- Alliance for Clinical Trials in Oncology
- National Cancer Institute (NCI)
Investigators
- Study Chair: Tracy Batchelor, MD, MPH, Massachusetts General Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CALGB-51101
- CALGB-51101
- CDR0000721927
- NCI-2012-00110